MUTYH and prion disease: Our observations of a significantly shortened clinical phase of prion disease in mice compromised in different BER enzyme activities, such as Mutyh and Ogg112 and here in Neil3 deficient mice suggest that during clinical prion disease, DNA glycosylase activities provide neuroprotection.